Details of the Drug

General Information of Drug (ID: DMMIQ20)

Drug Name
Patiromer calcium
Synonyms Patiromer; RLY-5016; Potassium binder (hyperkalemia), Relypsa
Indication
Disease Entry ICD 11 Status REF
Hyperkalemia 5C76 Approved [1]
Affected Organisms
Humans and other mammals
ATC Code
V03AE09: Patiromer calcium
V03AE: Drugs for treatment of hyperkalemia and hyperphosphatemia
V03A: ALL OTHER THERAPEUTIC PRODUCTS
V03: ALL OTHER THERAPEUTIC PRODUCTS
V: VARIOUS
ADMET Property
Elimination
The drug is excreted via feces []
Cross-matching ID
UNII
1FQ2RY5YHH
DrugBank ID
DB09263
TTD ID
D0Z2YQ

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Potassium (K) TTB0SC6 NOUNIPROTAC Binder [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT01810939) A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia. U.S. National Institutes of Health.
2 Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial. Eur Heart J. 2011 Apr;32(7):820-8.